Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
James B. Coutcher
Observed names:
Coutcher, J,
J B Coutcher,
J. Coutcher,
JB Coutcher
Institution:
Pfizer (United States)
Observed institutions:
Louisiana State University,
Pfizer (United States),
American Chemical Society,
University Medical Center New Orleans,
Louisiana State University Health Sciences Center New Orleans
OpenAlex ID:
A5035217846
A Selective Aldose Reductase Inhibitor of a New Structural Class Prevents or Reverses Early Retinal Abnormalities in Experimental Diabetic Retinopathy
2006
·
Wei Sun
, Peter J. Oates
, et al.
·
Diabetes
·
127
PDF
A Highly Selective, Non-Hydantoin, Non-Carboxylic Acid Inhibitor of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran- 2-sulfonyl)-2-H-pyridazin-3-one
2003
·
Banavara L. Mylari
, Sandra J. Armento
, et al.
·
Journal of Medicinal Chemistry
·
68
40th EASD Annual Meeting of the European Association for the Study of Diabetes
2004
·
M. Veitenhansl
, K. Stegner
, et al.
·
Diabetologia
·
67
A Novel Series of Non-Carboxylic Acid, Non-Hydantoin Inhibitors of Aldose Reductase with Potent Oral Activity in Diabetic Rat Models: 6-(5-Chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and Congeners
2005
·
Banavara L. Mylari
, Sandra J. Armento
, et al.
·
Journal of Medicinal Chemistry
·
66
Orally-Effective, Long-Acting Sorbitol Dehydrogenase Inhibitors: Synthesis, Structure−Activity Relationships, and in Vivo Evaluations of Novel Heterocycle-Substituted Piperazino-Pyrimidines
2001
·
Margaret Y. Chu-Moyer
, William E. Ballinger
, et al.
·
Journal of Medicinal Chemistry
·
47
Dietary choline supplementation increases the density of nicotine binding sites in rat brain.
1992
·
J B Coutcher
, G Cawley
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
30
Sorbitol Dehydrogenase Inhibitors (SDIs): A New Potent, Enantiomeric SDI, 4-[2-1R-Hydroxy-ethyl)-pyrimidin-4-yl]-piperazine-1-sulfonic Acid Dimethylamide
2001
·
Banavara L. Mylari
, Peter J. Oates
, et al.
·
Journal of Medicinal Chemistry
·
26
A Sorbitol Dehydrogenase Inhibitor of Exceptional in Vivo Potency with a Long Duration of Action: 1-(R)-{4-[4-(4,6-Dimethyl[1,3,5]triazin-2-yl)- 2R,6S-dimethylpiperazin-1-yl]pyrimidin-2- yl}ethanol
2002
·
Banavara L. Mylari
, Peter J. Oates
, et al.
·
Journal of Medicinal Chemistry
·
20
SAR and species/stereo-selective metabolism of the sorbitol dehydrogenase inhibitor, CP-470,711
2002
·
Margaret Y. Chu-Moyer
, William E. Ballinger
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
8
Orally‐Effective, Long‐Acting Sorbitol Dehydrogenase Inhibitors: Synthesis, Structure‐Activity Relationships, And In Vivo Evaluations Of Novel Heterocycle‐Substituted Piperazino‐Pyrimidines
2002
·
MY Chu‐Moyer
, WE Ballinger
, et al.
·
Journal of the Peripheral Nervous System
·
2
PDF
ChemInform Abstract: Sorbitol Dehydrogenase Inhibitors (SDIs): A New Potent, Enantiomeric SDI, 4‐[2‐(1R‐Hydroxy‐ethyl)‐pyrimidin‐4‐yl]‐piperazine‐1‐sulfonic Acid Dimethylamide.
2001
·
Banavara L. Mylari
, Peter J. Oates
, et al.
·
ChemInform
Show more works
View as search
Works count:
12
Citation count:
465
H-index:
8
I10-index:
8
Year
Topic
Type